This Government Contract opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Supply of Erythromycin 250mg Tablets (NSN: 6505010755095)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract requires the manufacture, packaging, labeling, and delivery of Erythromycin 250 mg tablets in 100-count units under National Stock Number 6505010755095, with strict adherence to all applicable federal medical and hazardous materials regulations. The product must meet precise quality and compliance standards to ensure suitability for military and federal healthcare use. Performance is specifically tied to Dyess Air Force Base, Texas, with delivery expected to meet the operational timelines of the Department of Defense’s Medical Supply Chain. The solicitation is submitted as a subcontract under NAICS code 325412, reflecting pharmaceutical manufacturing, and responses are due by July 22, 2026, with the opportunity posted on July 16, 2026. All parties must comply with federal procurement protocols and ensure end-to-end traceability, safety, and regulatory compliance throughout the supply chain.
General Info
Agency
NAICS
Place of Performance
DYESS AFB, TX, 79607-1367, USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-4181.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
ERYTHROMYCIN TABLETS
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
